Chemed (CHE) Share-based Compensation (2009 - 2026)

Chemed (CHE) has reported Share-based Compensation for 18 consecutive years, with $9.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Share-based Compensation rose 1.74% year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at $1.3 million (down 96.01% YoY), while the FY2025 annual figure was $1.1 million, down 96.49% from the prior year.
• Share-based Compensation came in at $9.2 million for Q1 2026 at Chemed, up from -$23.3 million in the prior quarter.
• The five-year high for Share-based Compensation was $30.8 million in Q4 2024, with the low at -$23.3 million in Q4 2025.
• Average Share-based Compensation over 5 years is $4.3 million, with a median of $8.4 million recorded in 2023.
• The largest YoY upside for Share-based Compensation was 299.05% in 2024 against a maximum downside of 402.38% in 2024.
• Year by year, Share-based Compensation stood at -$18.2 million in 2022, then surged by 142.4% to $7.7 million in 2023, then surged by 299.05% to $30.8 million in 2024, then plunged by 175.61% to -$23.3 million in 2025, then surged by 139.78% to $9.2 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $9.2 million, -$23.3 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.